Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
Slingshot Biosciences Strengthens UK and EU Presence with Synthetic Cell Mimic Technology

Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene thera...

February 06, 2026 | Friday | News
From Injections to Pills: How Mass Spectrometry Is Reshaping Biopharma

  Drug delivery is entering a period of rapid reinvention, driven as much by analytical innovation as by molecular design. In this BioPharma BoardRoo...

February 04, 2026 | Wednesday | Interaction
mRNA’s Next Act: Why Analytical Science Matters More Than Ever

As mRNA technologies move rapidly beyond COVID-19 into vaccines and therapies for cancer, rare diseases, and personalized medicine, scientific complexity i...

February 04, 2026 | Wednesday | Interaction
Automation, SPE, and Mass Spectrometry: The New Front Line of PFAS Regulation

As regulators worldwide intensify scrutiny of per- and polyfluoroalkyl substances (PFAS), laboratories are being pushed into a new era of sensitivity, sp...

February 04, 2026 | Wednesday | Interaction
AGC Biologics Earns Anvisa GMP Certification to Support Global Commercialization of Customer Biologics

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional d...

February 05, 2026 | Thursday | News
Formerra Expands Distribution of Evonik CARE Brand Medical Grades Across U.S. and Canada

Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada  Formerra, a leader in performance materials distribution, to...

February 05, 2026 | Thursday | News
Pfizer CEO Albert Bourla Signals Confidence in 2026 as Company Delivers Solid 2025 Results

Dr. Albert Bourla, Chairman and CEO of Pfizer, said: “With excellent execution in 2025, we delivered a solid financial performance and strengt...

February 05, 2026 | Thursday | Company results
AstraZeneca Deepens Weight Management Push With $1.2B AI-Driven Obesity Deal With CSPC

Agreement includes eight programmes, including a clinical-ready asset, plus access to advanced AI-driven peptide drug discovery platform and innovati...

February 03, 2026 | Tuesday | News
Tenacia and Golden Age Health Partner to Commercialize First-Ever Approved Treatment for CDD in China

First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform Tenacia Biopharmaceutical...

February 02, 2026 | Monday | News
Marc N. Casper Affirms Thermo Fisher’s Team-Driven Execution as 2025 Revenue Climbs to $44.6B

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and ful...

February 02, 2026 | Monday | Company results
Takeda CEO Christophe Weber Says FY2025 Is “Pivotal” as Company Raises Outlook Despite VYVANSE Erosion

  Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% atActual Exchange Rates (AER); Impact of VYVANSE® Generics is T...

February 02, 2026 | Monday | Company results
China’s NMPA Approves Almirall’s Seysara® for Moderate-to-Severe Acne

China’s National Medical Products Administration (NMPA) has approved Seysara®(sarecycline hydrochloride) for the treatment of inflammatory ...

January 30, 2026 | Friday | News
Elevar Submits NDA for Lirafugratinib as Second-Line FGFR2-Driven Cholangiocarcinoma Therapy

  Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating tre...

January 30, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close